Population pharmacokinetics of polymyxin b
WebFeb 1, 2024 · Population pharmacokinetics of polymyxin B was consistent with a three-compartment model. The clearance and distribution of the central compartment were 0.027 L/h/kg and 0.071 L/kg, respectively. Conclusions. This study is the first to examine the safety and pharmacokinetics of polymyxin B in healthy subjects. WebNov 22, 2024 · Population Pharmacokinetics and Limited Sampling Strategy for Therapeutic Drug Monitoring of Polymyxin B in Chinese Patients with Multidrug-Resistant Gram …
Population pharmacokinetics of polymyxin b
Did you know?
WebOct 3, 2016 · There were no considerable differences observed in the pharmacokinetics among major components of polymyxin B, and combining different components for pharmacokinetic analysis appeared reasonable. ABSTRACT Polymyxin B is increasingly used as a treatment of last resort for multidrug-resistant Gram-negative infections. … WebApr 10, 2024 · marcescens is intrinsically polymyxin resistant which is an antibiotic being used as a last resort to ... In all sessions, the number of Genetic Algorithm Parameters …
Web• Assisted in the coordination of a prospective clinical study for evaluation of the Pharmacokinetics and Pharmacodynamics (PK/PD) of therapeutic use of polymyxin B in … WebNov 18, 2024 · Polymyxin B is the last line of defense in treating multidrug-resistant gram-negative bacterial infections. Dosing of polymyxin B is currently based on total body weight, and a substantial intersubject variability has been reported. We evaluated the performance of different population pharmacokinetic models to predict polymyxin B exposures …
WebVoriconazole (VRC) is used as first line antifungal agent against invasive aspergillosis. Model-based approaches might optimize VRC therapy. This study aimed to investigate the predictive performance of pharmacokinetic models of VRC without pharmacogenetic information for their suitability for model-informed precision dosing. Seven PopPK models … WebJun 1, 2024 · The aim of this study was to assess the population pharmacokinetics (PK) of intravenous polymyxin B in patients with variable total body weights and create a …
WebMy strengths lie in communication, data-driven decision making, and problem solving. As a collaborative and multidisciplinary researcher, I bring a unique perspective to solving …
WebJun 18, 2024 · The population PK was determined using NONMEM and Monte Carlo simulation was performed to evaluate the exposures of different dosing regimens. … maintenance of expressive controlmaintenance of fire shuttersWebDec 14, 2024 · Polymyxin B is used as a last treatment resort for multidrug-resistant Gram-negative bacterial infections. The objectives of this study were to examine the population … maintenance of electric mixerWebApr 13, 2024 · Ozoralizumab (OZR), a tumor necrosis factor alpha (TNFα) inhibitor, is a NANOBODY® compound that binds to TNFα and human serum albumin. The main objective of this study was to analyze the pharmacokinetics (PK) of the drug and its correlation with clinical efficacy in patients with rheumatoid arthritis (RA). Efficacy data were analyzed … maintenance officer team leaderWebOct 28, 2024 · Though CAZ had lower synergistic rate with polymyxin B than MH, it had much better synergistic effect with polymyxin B, with the antibiotic susceptibility raised by approximate 8.3-fold by 1/4 MIC ... maintenance of fishing netsWebApr 1, 2024 · Population analysis profiles assessed emergence ... Polymyxin B achieved a reduction on the order of −2.05 ± 0.68 log10 CFU/ml ... Recent data on polymyxin pharmacokinetics (PK ... maintenance of fire extinguisher regulationsWebR-Praziquantel Integrated Population Pharmacokinetics in Preschool- and School-Aged African Children Infected with Schistosoma mansoni and S. haematobium and Lao ... Subcutaneously administered colistin and polymyxin B achieved a >2-log10 reduction in the bacterial load for P. aeruginosa and A. baumannii infections, while wound ... maintenance of frames and shutters